Kwality Pharmaceuticals Ltd
BSE:539997
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Kwality Pharmaceuticals Ltd
Depreciation & Amortization
Kwality Pharmaceuticals Ltd
Depreciation & Amortization Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Kwality Pharmaceuticals Ltd
BSE:539997
|
Depreciation & Amortization
₹193.7m
|
CAGR 3-Years
14%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Depreciation & Amortization
₹19.1B
|
CAGR 3-Years
17%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
Cipla Ltd
NSE:CIPLA
|
Depreciation & Amortization
₹11.4B
|
CAGR 3-Years
1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Depreciation & Amortization
₹27.2B
|
CAGR 3-Years
6%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
|
Lupin Ltd
NSE:LUPIN
|
Depreciation & Amortization
₹12.8B
|
CAGR 3-Years
11%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Depreciation & Amortization
₹8B
|
CAGR 3-Years
8%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
Kwality Pharmaceuticals Ltd
Glance View
Kwality Pharmaceuticals Pvt Ltd. engages in the manufacture of pharmaceutical formulations in dosage form. The company is headquartered in Amritsar, Punjab. The company went IPO on 2016-07-18. The firm operates through the segment of manufacturing a range of finished pharmaceutical formulations in a dosage form, such as tablets, liquid orals, powder for oral suspension, tablets, capsules, sterile powder for injections, small volume injectables, ointments, external preparations and oral rehydration solutions (ORS), among others. The company provides pharmaceutical formulations in various categories, such as beta-lactam and non-beta lactam, hormones and cytotoxic (oncology). The company manufactures beta-lactam and cephalosporin molecules in various dosage forms, such as tablets, capsules, dry powder for suspension and dry powder for injection. The company manufactures the anticancer products in various dosage forms, such as tablets, capsules and injectables. Its products are available in Europe, Africa and Asian countries, among others.
See Also
What is Kwality Pharmaceuticals Ltd's Depreciation & Amortization?
Depreciation & Amortization
193.7m
INR
Based on the financial report for Dec 31, 2025, Kwality Pharmaceuticals Ltd's Depreciation & Amortization amounts to 193.7m INR.
What is Kwality Pharmaceuticals Ltd's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 3Y
14%
Over the last year, the Depreciation & Amortization growth was 4%. The average annual Depreciation & Amortization growth rates for Kwality Pharmaceuticals Ltd have been 14% over the past three years .
